Sign in
PRENW Stock Price, Chart, Stats & News
Prenetics Global Limited
Save
Prenetics Global Limited (PRENW) does not currently pay a dividend.
320.12M
Market cap
–
Current P/E
–
Forward P/E
PRENW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 52.99% |
Operating margin | -41.27% |
Pretax margin | -60.12% |
Net margin | -61.32% |
Effective tax rate | 0.08% |
ROA | -28.66% |
ROE | -36.02% |
D/E | 0.01x |
Interest coverage ratio | -167.74x |
PRENW valuation
P/E | – |
P/S | 3.03x |
P/B | 1.88x |
P/CF | -15.07x |
P/FCF | -13.08x |
P/OCF | -15.07x |
PEG | 0.44x |
EV multiple | -7.76x |
About
Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform.
Similar securities
Based on sector and market capitalization
Report issue